J.P. Boulenger
Impact in
-
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Biological Psychiatry top 5%
- Tryptophan and brain disorders
Papers in
-
- Psychosomatic Disorders and Their Treatments 6
- Schizophrenia research and treatment 6
- Attention Deficit Hyperactivity Disorder 3
-
- Adenosine and Purinergic Signaling 3
- Co-authors
- Paul J. MarangosJitendra PatelThomas W. UhdeJean‐Claude BaronE. ZarifianD CastelnauP. CourtetDominique Mouthon
- Journals
- European Neuropsychopharmacology (4 papers)L Encéphale (3 papers)Biological Psychiatry (2 papers)Value in Health (2 papers)Neuroscience & Biobehavioral Reviews (1 paper)
- Partner nations
- FranceUnited StatesSwitzerland
In The Last Decade
J.P. Boulenger
44 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 109
- Cellular and Molecular Neuroscience 569
- Biological Psychiatry 76
- Behavioral Neuroscience 100
- Physiology 83
- Psychiatry and Mental health 249
Countries citing papers authored by J.P. Boulenger
This map shows the geographic impact of J.P. Boulenger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.P. Boulenger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.P. Boulenger more than expected).
Fields of papers citing papers by J.P. Boulenger
This network shows the impact of papers produced by J.P. Boulenger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.P. Boulenger. The network helps show where J.P. Boulenger may publish in the future.
Co-authors
The 25 scholars most cited alongside J.P. Boulenger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 20 | |
| 2 | 2013 | 7 | |
| 3 | 2013 | 1 | |
| 4 | 2013 | 6 | |
| 5 | 2010 | 15 | |
| 6 | 2006 | 6 | |
| 7 | 2002 | 56 | |
| 8 | [Clinical impact of atypical antipsychotics: prospective 6-month study of inpatients treated with risperidone or olanzapine]. | 2002 | 3 |
| 9 | 2001 | 142 | |
| 10 | Prescription hospitalière de la rispéridone et de l'olanzapine : enquête et recommandations | 2000 | 1 |
| 11 | 1999 | 40 | |
| 12 | 1992 | 83 | |
| 13 | 1991 | 7 | |
| 14 | 1990 | 1 | |
| 15 | 1989 | 16 | |
| 16 | 1989 | 13 | |
| 17 | 1989 | 100 | |
| 18 | 1989 | 1 | |
| 19 | 1988 | 10 | |
| 20 | La caféine, le stress et l'anxiété | 1985 | 1 |
About J.P. Boulenger
J.P. Boulenger is a scholar working on Psychiatry and Mental health, Physiology, Cellular and Molecular Neuroscience, Behavioral Neuroscience and Pharmacology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (7 papers), Psychosomatic Disorders and Their Treatments (6 papers), Schizophrenia research and treatment (6 papers), Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (5 papers), Treatment of Major Depression (5 papers), Psychoanalysis and Psychopathology Research (4 papers), Attention Deficit Hyperactivity Disorder (3 papers) and Adenosine and Purinergic Signaling (3 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (569 citations), Biological Psychiatry (76 citations), Behavioral Neuroscience (100 citations), Physiology (83 citations) and Psychiatry and Mental health (249 citations). J.P. Boulenger has collaborated with scholars based in France, United States and Switzerland. Frequent co-authors include Paul J. Marangos, Jitendra Patel, Thomas W. Uhde, Jean‐Claude Baron, E. Zarifian, D Castelnau, P. Courtet, Dominique Mouthon, Catherine Burési and R M Post. Their work appears in journals such as European Neuropsychopharmacology, L Encéphale, Biological Psychiatry, Value in Health and Neuroscience & Biobehavioral Reviews.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.